AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 282 filers reported holding AMEDISYS INC in Q3 2023. The put-call ratio across all filers is 10.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,006 | -51.3% | 3,981 | -52.4% | 0.00% | 0.0% |
| Q2 2023 | $764,091 | +27.3% | 8,358 | +2.6% | 0.00% | 0.0% |
| Q1 2023 | $600,395 | -13.1% | 8,150 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $690,605 | -18.8% | 8,263 | -6.0% | 0.00% | -50.0% |
| Q3 2022 | $851,000 | -14.3% | 8,789 | -7.2% | 0.00% | 0.0% |
| Q2 2022 | $993,000 | -45.9% | 9,469 | -10.4% | 0.00% | -50.0% |
| Q1 2022 | $1,834,000 | +6.0% | 10,565 | -1.3% | 0.00% | +33.3% |
| Q4 2021 | $1,731,000 | +22.0% | 10,699 | +12.3% | 0.00% | 0.0% |
| Q3 2021 | $1,419,000 | -31.5% | 9,525 | +12.5% | 0.00% | -25.0% |
| Q2 2021 | $2,073,000 | -56.1% | 8,468 | -52.5% | 0.00% | -63.6% |
| Q1 2021 | $4,725,000 | +18.2% | 17,828 | +30.8% | 0.01% | 0.0% |
| Q4 2020 | $3,996,000 | +39.2% | 13,630 | +11.2% | 0.01% | +22.2% |
| Q3 2020 | $2,870,000 | +18.9% | 12,253 | +0.8% | 0.01% | +12.5% |
| Q2 2020 | $2,414,000 | +11.3% | 12,154 | +2.8% | 0.01% | -11.1% |
| Q1 2020 | $2,168,000 | – | 11,821 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |